ULTRAGENYX PHARMACEUTICAL INC. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
ULTRAGENYX PHARMACEUTICAL INC. (RARE) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $1.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-02-18
- ULTRAGENYX PHARMACEUTICAL INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $1.00M.
- ULTRAGENYX PHARMACEUTICAL INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $0.00.
- ULTRAGENYX PHARMACEUTICAL INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- ULTRAGENYX PHARMACEUTICAL INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $259.00K, a 29.50% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.00M 10-K · filed 2026-02-18 | |
| 2024-12-31 | $0.00 10-K · filed 2026-02-18 | |
| 2023-12-31 | $0.00 10-K · filed 2026-02-18 | |
| 2022-12-31 | $259.00K 10-K · filed 2025-02-19 | |
| 2021-12-31 | $200.00K 10-K · filed 2024-02-21 | |
| 2020-12-31 | $624.00K 10-K · filed 2023-02-17 | |
| 2016-12-31 | $18.16M 10-K · filed 2019-02-20 | |
| 2015-12-31 | $4.40M 10-K · filed 2018-02-21 | -$4.40M 10-K · filed 2016-02-26 |
| 2013-12-31 | $5.00K 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |